Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleAll together now?AbstractThe imminent advent of a global exchange is unlikely to be a panacea for the financial ills that currently beset European biotech.SubjectsEUROPEAN Union countries; BIOTECHNOLOGY industries; FINANCIAL crises; NASDAQ Financial Products Services Inc.; GOVERNMENT financial institutions; LONDON Stock ExchangePublicationNature Biotechnology, 2006, Vol 24, Issue 12, p1454ISSN1087-0156Publication typeEditorialDOI10.1038/nbt1206-1454